ARTICLE | Clinical News
Chiron, Evans Medical Ltd. regulatory update
March 23, 1998 8:00 AM UTC
CHIR said that the European Patent Office revoked Evans's Patent No. 0 162 639 covering the pertactin antigen of Bordetella pertussis, which is used in CHIR's acellular pertussis vaccine. SmithKline ...